Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166114 · ClinicalTrials.gov registry record · Phase 4
Depression, Epinephrine, and Platelet Function
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00166114 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 40 participants.
The verdict
NCT00166114, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
Men and women who have suffered sexual and/or physical abuse before the age of 12 are at increased risk for anxiety and mood disorders, other serious psychiatric disorders, and likely medical illnesses. What is not known is whether adult survivors of childhood adversity experience heightened negative emotions and increased physical responses due to altered norepinephrine or serotonin systems in their brains and bodies. The investigators expect to see that survivors of childhood adversity experience heightened negative emotions and increased physical responses to stress.
Interventions
- DRUG Escitalopram
- DRUG Desipramine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2002-02 |
| Est. Completion | 2009-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00166114
The ClinicalTrials.gov registry entry for NCT00166114 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Escitalopram is the first listed.
NCT00166114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00166114 about?
NCT00166114 is a clinical study titled "Depression, Epinephrine, and Platelet Function". Men and women who have suffered sexual and/or physical abuse before the age of 12 are at increased risk for anxiety and mood disorders, other serious psychiatric disorders, and likely medical illnesses. What is not known is whether adult survivors of childhood adversity experience heightened negativ...
What is the current status of trial NCT00166114?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2002-02. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00166114?
The interventions under investigation include: Escitalopram (DRUG), Desipramine (DRUG).
Who is sponsoring clinical trial NCT00166114?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.